ROCKVILLE, Md., Aug. 12 /PRNewswire/ -- OriGene Technologies, Inc., a gene-centric life sciences company, announces the acquisitionof Blue Heron Biotechnology, a pioneer in the gene synthesis business since 1999.
Blue Heron is one of the oldest and most successful gene synthesis companies in the world, providing customers solutions for complex DNA synthesis. It supplies
"Blue Heron has an impressive history of high product quality and outstanding customer service. We are extremely excited about Blue Heron joining OriGene and our combined capabilities to provide total solutions to our customers. We are 100% committed to serving our customers with high quality, strict confidentiality standards, and improved business efficiency. This latest purchase is a further indication of OriGene's determination to expand its gene-centric tools portfolio for the life sciences research and drug discovery community," said Dr. Wei-Wu He, OriGene's Chairman and Chief Executive Officer.
About OriGene Technologies
OriGene Technologies, Inc., is a gene-centric life sciences company dedicated to support academic, pharmaceutical and biotech companies in their research of gene functions and drug discovery. OriGene's gene based toolbox allows life science researchers to study all genes and gene functions. OriGene's mission is to be "Your Gene Company", and we are dedicated to develop the most comprehensive technology and tools for everything a researcher would need for gene based research. For more information, visit www.origene.com.
SOURCE OriGene Technologies, Inc.
Subscribe to our Free Newsletters!
Cholestatic jaundice occurs when the flow of bile (chole) between the liver and small intestine is ...
Opportunistic infections are microbial infections that can cause disease in persons with a weak ...
The state health insurance programs provide health care support to the below poverty line (BPL) ...View All